Skip Navigation Bar
National Intitutes of Health
This finding aids platform will be replaced in Fall 2022. Please explore the new platform Beta soft release by visiting https://archivesspace.nlm.nih.gov

John Adriani Papers, 1925-1988
search terms in context | full text File Size: 617 K bytes | Add this to my bookbag

 
Box | Folder Title
 
Pharmaceutical Evaluations and Consulting, 1925-1988, [series]:

The Pharmaceutical Evaluations and Consulting Series contains material Adriani accumulated during his service as a pharmaceutical consultant to the federal government (especially to the Food and Drug Administration), to private organizations such as the American Medical Association (AMA) and its Council on Drugs, and to private industry. The material has been separated into four different subseries: evaluation of pharmaceutical products undertaken for private companies; evaluation of and consulting on pharmaceuticals undertaken by various committees and task groups for government agencies; evaluation of and consulting on pharmaceuticals undertaken by the AMA Council on Drugs; and materials on other advisory projects undertaken by Adriani.

 
Pharmaceutical Manufacturers, 1949-1986 [subseries]:

The Pharmaceutical Manufacturers' subseries consists of correspondence with pharmaceutical manufacturers, both general and relating to specific drug products. More than twenty-five different firms are represented and perhaps forty drug products discussed. Adriani kept one set of files of general correspondence organized by manufacturer and another set organized by specific product. These have been combined, and the specific products are listed under the name of the manufacturer. Large or important files have been reorganized in forward chronological order; others have not been reorganized. Much of the correspondence is routine, but there are many letters of interest regarding research on and use of specific drugs. In light of some of his public stances, Adriani's relationship with the companies is intriguing. Some files contain case notes with specific patient names, and these have been marked [RESTRICTED PHI POLICY]. Consult the manuscripts curator regarding access.

20 1
Abbott Laboratories, 1951, 1956-1985
20 2
Abbott Laboratories: Megimide, 1957
20 3
Abbott Laboratories: Penthrane, 1959-1970
20 4
Abbott Laboratories: Pentothal, 1957-1975
20 5
Airco/Ohio Medical Products: Enflurane, 1979-1981
20 6
American Cyanamid Company, 1961
20 7
Arnar-Stone Laboratories, Inc., 1950-1954
20 8
Arnar-Stone Laboratories, Inc., 1955-1959
20 9
Arnar-Stone Laboratories, Inc., 1960-1964
20 10
Arnar-Stone Laboratories, Inc., 1965-1978
20 11
Arnar-Stone Laboratories, Inc./American Critical Care, 1979-1982
20 12
Astra Pharmaceutical Products: 1963-1984
20 13
Astra Pharmaceutical Products: Xylocaine, 1957[?]-1969
20 14
Ayerst Laboratories, 1957-1972
20 15
Ayerst Laboratories: Fluothane, 1956-1974
21 1
Baxter-Travenol Laboratories, 1957-1974
21 2
Baxter-Travenol Laboratories: Dyclone, 1960-1964
21 3
Baxter-Travenol Laboratories: parenterals in plastic, 1966-1969
21 4
Bilhuber-Knoll Corp.: Paracodin, 1956-1957
21 5
Burroughs-Wellcome & Company, 1956-1958
21 6
Campbell Pharmaceuticals, 1959-1960
21 7
Cetylite Industries: Cetacaine research, ca. 1977
21 8
Cetylite Industries: Cetacaine, 1978-1986
21 9
Cetylite Industries: Cetacaine - Eldred, John, 1977-1986
22 1
Ciba Pharmaceuticals, 1949-1967
22 2
Ciba Pharmaceuticals: Ritalin, 1956-1957
22 3
Ciba Pharmaceuticals: Investigations, various products, 1957-1960
22 4
Combe Laboratories: Lanacaine/Benzocaine, 1982-1986
22 5
Cutter Laboratories, 1957-1965
22 6
Cybersol, 1970-1972
22 7
Dewey & Almy Chemical Company, 1956-1957
22 8
Dome Chemicals, Inc., 1961
22 9
Dow Chemical Company, 1962
22 10
Eaton Laboratories, 1964-1965
22 11
Edison, Thomas, Inc., 1957
22 12
Endo Laboratories, 1959-1972
22 13
Endo Laboratories: Benzydamine, 1978-1982
22 14
Endo Laboratories: Numorphan - Meperidine, 1959-1965
22 15
Ethicon, Inc., 1958-1959
23 1
FBA Pharmaceuticals, Inc.: Bayer 1420, 1962-1965
23 2
E. Fougera and Company: Efocaine, 1951-1953, 1956
23 3
E. Fougera and Company: Laudolissin, 1953-1955
23 4
Geigy Pharmaceuticals, 1954, 1959-1965
23 5
High Chemical Company: Sarapin, 1978-1981
23 6
Hoffmann-LaRoche, Inc., 1953-1960
23 7
Hoffman-LaRoche, Inc., 1961-1975
23 8
Hoffmann-LaRoche, Inc.: Romilar, 1956-1958j
23 9
Hoffmann-LaRoche, Inc.: Tigan, 1958-1964
23 10
Hoffmann-LaRoche, Inc.: Valium, 1963-1968
23 11
Irwin, Neisler, & Co., 1956-1960
23 12
Kirk, C.F. Laboratories, 1976
23 13
Kremers-Urban Company: Levsin sulfate, 1955-1957, 1966-1972
23 14
Lederle Laboratories, 1950-1967
23 15
Lilly Research Laboratories, 1955-1960
23 16
Lilly Research Laboratories: Darvon, 1957-1967
23 17
Lilly Research Laboratories: Methohexital, 1956-1961
24 1
Mallinckrodt Pharmaceuticals, 1956-1962
24 2
Maltbie Laboratories, 1959
24 3
Maltbie Laboratories: Chlorocaine, Nesacaine, 1957
24 4
Marion Laboratories (Wood, Merle E.), 1972-1988
24 5
Massengill, S.E., Co., 1956-1957
24 6
McNeil Laboratories, 1956-1968
24 7
McNeil Laboratories: Flexin/Paraflex, 1955-1959
24 8
McNeil Laboratories: Innovar, 1963-1975
24 9
Mead Johnson & Co., 1958-1960
24 10
Merck, Sharp & Dohme, 1955-1970, 1981-1982
24 11
Merck, Sharp & Dohme: leridine, 1955-1958
24 12
Merck, Sharp & Dohme: Suavatil, 1956-1957
24 13
Merck, Sharp & Dohme: various products, 1951-1956
24 14
Merrell, William S., Co., 1954-1956
24 15
Merrell, William S., Co.: Dolitrone, 1954-1956, 1961
24 16
Miles Laboratories: Bactine, 1963-1966
24 17
Mizzy, Inc., 1963
24 18
Morton Pharmaceuticals, 1955-1956
24 19
Nicholas, A. & G. Inc.: Megimide, Deptazole, 1956-1957
24 20
Nordmark Pharmaceuticals, 1957
24 21
Northland Pharmacal Co., 1957
24 22
Norwich-Eaton Pharmaceuticals: Dyclonine, 1981-1985
24 23
Novocol Chemical Mfg. Co., 1956-1957
25 1
Ohio Chemical and Surgical Equipment Co., 1955
25 2
Parke-Davis & Co., 1950-1968
25 3
Pfizer Laboratories, 1956-1962, 1970-1971
25 4
Pfizer Laboratories: Viadril, 1955-1957
25 5
Pfizer Laboratories: Vistaril, 1960-1961, 1971j
25 6
Pharmaco, Inc., 1970
25 7
Pitman-Moore (Dow), 1955-1967
25 8
Pitman-Moore (Dow): Dyclone, 1955-1965
25 9
Purdue Frederick Research Center, 1962-1965
25 10
Riker Laboratories, 1956-1973
25 11
A.H. Robins Company: Dopram (Doxapram), 1962-1965
25 12
A.H. Robins Company: Robaxim, 1957-1959
25 13
Roerig: Atarax, 1959
25 14
Sandoz Pharmaceuticals, 1955-1965
25 15
Sandoz Pharmaceuticals: Felypressin - Oxypressin, 1964-1968
25 16
Schering Corporation, 1952-1973
25 17
Searle, G.D., 1966, 1980
25 18
Sharp & Dohme, 1954-1956
25 19
Sharp & Dohme: Cylcaine, 1954-1956
25 20
Sharp & Dohme: Nalline, 1955-1957
25 21
Sharp & Dohme: S.D. 1131-667, 1955-1956, 1963
25 22
Smith, Kline, & French, 1947-1984
26 1
Squibb, E.R., & Sons/Squibb Institute for Medical Research, 1950-1968j
26 2
Squibb Institute for Medical Research: Bandol, 1963-1966
26 3
Squibb Institute for Medical Research: Propylene, c. 1959
26 4
Squibb Institute for Medical Research: Vesprin, 1957-1959
26 5
Sterling-Winthrop Laboratories, 1956-1958
26 6
Sterling-Winthrop Laboratories: Talwin, 1963-1967
26 7
Syntex Laboratories, 1963-1964
26 8
Upjohn Company, 1955-1959, 1970
26 9
USV Pharmaceuticals (Arlington-Funk) Laboratories, 1959, 1967
26 10
Wallace Laboratories: Miltown, 1958-1968
26 11
Warner Lambert Research Insititute, 1958-1959, 1966
26 12
Winthrop Laboratories (Winthrop-Stearns), 1955-1969
26 13
Winthrop Laboratories: Carbocaine, 1958-1963
26 14
Winthrop Laboratories: Lotusate, 1955-1956
26 15
Winthrop Laboratories: Pontocaine, 1956-1966
26 16
Winthrop Laboratories: Pressonex, 1960
26 17
Winthrop Laboratories: Sympocaine, 1954-1955
26 18
Winthrop Laboratories: WIN 7969, 1955-1957
26 19
Winthrop Laboratories: Carbocaine - Pontocaine - Tetracaine comparative studies, 1952-195?
26 20
Winthrop-Stearns "Gray Books", 195?
27 1
Wyeth Laboratories, 1954-1986
27 2
Commercial names, 1960
27 3
Miscellaneous companies, 1959-1987
27 4
Miscellaneous compounds, 195?, 1971, 1976
 
AMA Council on Drugs Subseries, 1964-1988 [subseries]:

The second subseries consists of AMA Council on Drugs materials (1968-1972). This consists of correspondence with Council members and AMA staff, agendas, administrative memoranda, and some files related to specific drug issues. Much of the material deals with the publication of an article and editorial in the Journal of the American Medical Association on "The Package Insert" in 1969, the writing and publication of the AMA-Drug Evaluation books in 1971 and 1972, and the dissolution of the Council on Drugs in 1972. There are a great many interesting items relating to drug evaluation and labelling, FDA relations, and AMA in-house politics. As with other files, Adriani's own letters predominate. There is also, however, much correspondence from others, including John Ballin, Harry Dowling, Thomas Hayes, Hugh Hussey, Max Parrott, Harry Shirkey and Jean Weston.

 
Council on Drugs: meeting agendas, 1965?-1972 [subseries]:
27 5
Background/agenda, fall 1965?
27 6
Agenda, October 1966
27 7
Agenda, May 1967
27 8
Agenda, September 1967
27 9
Agenda, January 1968
27 10
Background/agenda, May 1968
27 11
Background/agenda, September 1968
27 12
Background/agenda, May 1969
27 13
Background/agenda, September 1970
28 1
Background/agenda, January 1971
28 2
Background/agenda, May 1971
28 3
Agenda, September 1971j
28 4
Agenda, January 1972
28 5
Agenda, May 1972
28 6
Agenda, September 1972
 
AMA-Drug Evaluations, 1964-1971 [subseries]:
28 7
Chapter revisions, 1st edition, c. 1970
29 1
Chapter revisions, 2nd edition, c. 1971
29 2
Correspondence, 1968-1969
29 3
Correspondence, 1970-1973
29 4
Correspondence from readers, 1969-1979
29 5
Press comment, 1970-1971
29 6
Council on Drugs Bulletins, 1964-1967
29 7
Council on Drugs Bulletins, 1968
29 8
Council on Drugs Bulletins, January-September 1969
29 9
Council on Drugs Bulletins, October-December 1969
30 1
Council on Drugs bulletins, 1970-1971
 
Drug issues, 1960-1971 [subseries]:
30 2
Kanamycin, Edecrin, 1968
30 3
Ketamine, 1970-1971
30 4
Medicinal oxygen, 1968
30 5
Miscellaneous (arranged alphabetically), 1960, 1965, 1968
30 6
Panalba, 1969-1971
30 7
University Group Diabetes Program, 1970-1971
30 8
Drug Utilization Committee, 1967-1971
30 9
Fountain Committee controversy, 1964-1965
30 10
Council on Drugs guidelines, 1968-1969
30 11
HEW Formulary Committee, 1970-1971
30 12
International Conference on Adverse Reaction Reporting Systems, October 1970
30 13
Joint meeting of the Council on Drugs and the National Research Council, October 19, 1971
30 14
Louisiana resolution to retain the Council on Drugs, 1972
30 15
Memoranda, 1964-1971
31 1
National Drug Advisory Commission, 1969-1974
31 2
Organization of the Council on Drugs, undated
 
"Package Insert" [Article by Adriani], 1968-1970 [subseries]:
31 3
Correspondence, 1968j
31 4
Correspondence, 1969
31 5
Manuscripts and drafts, 1968
31 6
Additional material, 1968-1969
31 7
Package inserts, 1968-1969
31 8
Pamphlets, 1967-1968
31 9
Council on Drugs: miscellaneous, 1960-1970
 
Council on Drugs correspondence, 1958-1984 [subseries]:
31 10
AMA Board of Trustees, 1967-1971
31 11
AMA Department of Drugs staff, 1958-1982
31 12
Annis, Edward R., 1968-1969
31 13
Azarnoff, Daniel L., 1969-1978
32 1
Ballin, John C., 1968-1973
32 2
Barclay, William R., 1970-1971
32 3
Bass, Allan D., 1968-1973, 1976
32 4
Blasingame, F.J.L. "Bing", 1963-1973
32 5
Cluff, Leighton E., 1968-1969
32 6
Curry, John, 1968-1971
32 7
David, Norman A., 1968-1972
32 8
DeNosaquo, Norman, 1962-1970
32 9
Dorman, Gerald, 1969
32 10
Dowling, Harry F., 1965-1973
32 11
Freis, Edward D., 1969-1970
32 12
Grater, William C., 1967-1976
32 13
Greiner, Theodore H., 1966-1969
32 14
Hall, Wesley W., 1970-1971
32 15
Hayes, Thomas H., 1966-1968
32 16
Hayes, Thomas H., 1969-1970
32 17
Hossley, William J., 1970-1973
32 18
Howard, Ernest B., 1968-1972
32 19
Howard, John M., 1960, 1968
32 20
Hussey, Hugh H., 1965-1972
33 1
Joint Commission on the Accreditation of Hospitals, 1967-1970
33 2
Kernodle, John, 1968-1973
33 3
Kirsner, Joseph B., 1968-1971
33 4
LaPointe, Roland E., 1963-1982
33 5
Leopold, Irving H., 1970-1971
33 6
Moser, Robert H., 1968-1973
33 7
National Association of Pharmaceutical Manufacturers, 196-1970
33 8
National Pharmaceutical Council (Weston, Jean K.), 1966-1967
33 9
Parrott, Max H., 1968-1971, 1976
33 10
Paulsen, C. Alvin, 1969-1972
33 11
Rogers, Daniel M., 1968-1970
33 12
Sherry, Sol, 1967-1968
33 13
Shirkey, Harry C., 1962-1968
33 14
Shirkey, Harry C., January-June 1969
33 15
Shirkey, Harry C., July-December 1969
33 16
Shirkey, Harry C., 1970-1984
33 17
Simeone, F.A., 1965-1972
34 1
Smith, Donn L., 1968-1975
34 2
Student American Medical Association, 1969
34 3
Weston, Jean K., 1964-1971
34 4
Wintrobe, Maxwell, 1966-1973
34 5
Wolman, Walter, 1968, 1970-1971
34 6
Woods, Lauren A., 1968-1973
34 7
Miscellaneous correspondence, 1968-1973
 
Food and Drug Administration, 1963-1988 [subseries]:
34 8
FDA: general, 1963-1987
34 9
FDA regulations and guidelines, 1967-1974
 
FDA Advisory Work, 1963-1988 [subseries]:
34 10
Ad Hoc Committee on Chloramphenicol, 1968-1969
34 11
Advisory Committee on Investigational Drugs: administrative correspondence, 1963-1964
34 12
Advisory Committee on Investigational Drugs: agendas/minutes, 1963-1965
34 13
Advisory Committee on Investigational Drugs: correspondence, 1963-1965
34 14
Advisory Committee on Investigational Drugs: papers and background materials, 1963-1965
35 1
Over the Counter (OTC) Panel, 1971-1974
35 2
OTC Panel, 1975-1977
35 3
OTC Panel, 1978
35 4
OTC Panel, January-June 1979
35 5
OTC Panel, July-December 1979
35 6
OTC Panel, 1980-1982; 1986-1988
35 7
OTC Panel: work papers, topical analgesics, 1973-1974
35 8
OTC Panel: work papers, topical analgesics, 1975-1978
35 9
OTC Panel: final report on topical analgesics, 1977
36 1
Respiratory and Anesthetic Drugs Advisory Committee, 1966-1969
36 2
Respiratory and Anesthetic Drugs Committee: Doxapram, 1968
36 3
Respiratory and Anesthetic Drugs Committee: Fluoramar, 1968
36 4
Respiratory and Anesthetic Drugs Committee: Halothane, 1967
36 5
Respiratory and Anesthetic Drugs Committee: Penthrane, 1967, 1969
36 6
Review Committee of the Task Force on Prescription Drugs, 1967-1969
36 7
Review Committee of the Task Force on Prescription Drugs: comments of members: Adriani-Hutton, 1969
36 8
Review Committee of the Task Force on Prescription drugs: comments of members: Mattia-Zimmer, 1969
36 9
FDA Background materials, 196[?], 1979
 
FDA Correspondence, 1953-1983 [subseries]:
36 10
Clark, Margaret A., 1968-1970
36 11
de Haen, Paul, 1970-1971
36 12
Egeberg, Roger O., 1969
36 13
Giambalvo, Joan F., 1967-1971
36 14
Kefauver-Harris Amendments, 1962
36 15
Kilburn, Donald N., 1981-1982
36 16
Ley, Herbert L., Jr., 1968-1970
36 17
Miscellaneous, 1953-1976, 1982
36 18
Proprietary Association, 1980-1983
36 19
Wolfson, I. David, 1977-1978
 
FDA appointment (Bureau of Medicine directorship), 1969-1970 [subseries]:
37 1
Correspondence, 1969
37 2
Press and Public reaction, August 1969
37 3
Press and public reaction, September 1969-June 1970
 
Other Advisory Projects, 1954-1984 [subseries]:
37 4
Council of Better Business Bureaus (Vacheron, David L.), 1975-1976
 
Federal Trade Commission Consulting, 1970-1983 [subseries]:
37 5
Aspercreme, TEA/S, 1980-1982
37 6
Aspercreme, 1980-1983
37 7
Pfizer "UnBurn", 1970-1972
37 8
Department of Health, Education and Welfare advisory work, 1954-1972; 1979
37 9
Miscellaneous advisory projects (drug-related), 1970-1984
37 10
National Formulary, 1969, 1971-1973
 
National Research Council, 1954-1972 [subseries]:
38 1
Agendas and reports, 1954-1958
38 2
Agendas and reports, 1959-1961
38 3
Agendas and reports, 1966
38 4
Correspondence (Bradley, Thomas; Tredler, Duke), 1956-1972
 
U.S. Pharmacopoeia, 1959-1980 [subseries]:
38 5
Administrative memoranda, 1960-1974
38 6
Correspondence, 1959-1966
38 7
Corresondence, 1967-1974; 1979
38 8
Conventions, 1971-1975
38 9
Convention, 1979-1980